Choose your question from the below

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

KnolScapes: Strategic Analysis Capabilities

KnolScapes helps teams create and analyze market access strategies through its comprehensive analysis of HTAs, pricing models, and value stories. The platform enables real-time collaboration across global teams while maintaining data consistency and accuracy.

AI-Powered Systematic Literature Reviews with Regulatory Precision

Knolens SLR is an AI-powered platform that automates systematic literature reviews using the industry-standard PICOS methodology. It streamlines the entire SLR process from literature identification and screening to data extraction and synthesis, allowing researchers to efficiently conduct comprehensive reviews and test different hypotheses with full regulatory traceability.

What is Knolens KnolScapes?

Unified Intelligence for Strategic Drug Development

Knolscapes is an intelligence platform providing personalized, multi-dimensional analysis across therapeutic landscapes, diseases, and HTA assessments. It offers real-time, configurable analytics that integrate clinical, market, and competitive data to support cross-functional decision-making throughout drug development, saving thousands of hours and reducing costly missteps

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

Accelerated intelligence: From siloed processes to synchronized decisions

By eliminating information silos and providing real-time, validated insights to all stakeholders simultaneously, Knolens reduces decision cycles from weeks to days.

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

One truth, multiple perspectives: Precision insights that unify your organization

Knolens maintains a single source of truth with centralized data governance, ensuring all teams work from identical, validated information regardless of functional perspective

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

Cross-functional intelligence: One platform, multiple perspectives, aligned decisions

Knolens creates a unified intelligence hub where cross-functional teams access the same verified insights, enabling seamless collaboration and aligned decision-making across departments.

Cross-functional intelligence: One platform, multiple perspectives, aligned decisions

Knolens creates a unified intelligence hub where cross-functional teams access the same verified insights, enabling seamless collaboration and aligned decision-making across departments.

Cross Functional

Choose your question from the below

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

AI-Powered Systematic Literature Reviews with Regulatory Precision

Knolens SLR is an AI-powered platform that automates systematic literature reviews using the industry-standard PICOS methodology. It streamlines the entire SLR process from literature identification and screening to data extraction and synthesis, allowing researchers to efficiently conduct comprehensive reviews and test different hypotheses with full regulatory traceability.

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.
Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

PICOS framework: From complex trial data to structured evidence

Knolens SLR automates data extraction from full-text papers with comprehensive coverage of 500+ variables. The platform maintains high accuracy while significantly reducing manual effort in systematic reviews.

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

Interactive Competitive Landscape Mapping for Strategic Drug Development

KnolScapes visualizes competitive drug development through interactive layered visuals like this radial chart, allowing users to filter by company, phase, status, and drug. This multi-dimensional view reveals relationships between competitors, trial phases, and indications, providing strategic insights for market positioning, evidence gaps, and access planning opportunities.

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

Economic Burden for UC in US and Europe

Knolens integrates prevalence, treatment patterns, and cost data to generate customizable budget impact models tailored to specific payer requirements and markets.

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

Economic Burden for UC in US and Europe

Knolens integrates prevalence, treatment patterns, and cost data to generate customizable budget impact models tailored to specific payer requirements and markets.

HEOR 

Choose your question from the below

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

AI-Powered Systematic Literature Reviews with Regulatory Precision

Knolens SLR is an AI-powered platform that automates systematic literature reviews using the industry-standard PICOS methodology. It streamlines the entire SLR process from literature identification and screening to data extraction and synthesis, allowing researchers to efficiently conduct comprehensive reviews and test different hypotheses with full regulatory traceability.

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.
Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

KnolScapes: Strategic Analysis Capabilities

Knolens KnolScapes helps teams create and analyze market access strategies through its comprehensive analysis of HTAs, pricing models, and value stories. The platform enables real-time collaboration across global teams while maintaining data consistency and accuracy.

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

Comparison of combination drugs in endometrial cancer

Knolens analyzes efficacy, safety, and cost data across combination regimens, identifying the most compelling value drivers for your endometrial cancer therapy's HTA submissions

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.
Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.
Market Access

Choose your question from the below

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.
Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.
Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

Endpoint mapping: Precision trial design for targeted patient populations

Knolens evaluates endpoint selection patterns across successful regulatory submissions and HTA approvals, guiding selection of endpoints that satisfy both regulatory and market access requirements

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

Challenges in Patient recruitment for endometrial cancer

Knolens identifies historical recruitment bottlenecks and successful strategies, enabling optimized site selection and enrollment criteria for your endometrial cancer trials.

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.
Clinical Development

Choose your question from the below

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.
Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.
Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

Emerging biomarkers for Endometrial Cancer

Knolens systematically aggregates biomarker research across publications and trials, creating comprehensive scientific narratives with full citation traceability

Medical Affairs

Choose your question from the below

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.
Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.
Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

Competitive Landscape for Endometrial Cancer

Knolens creates comprehensive competitive maps, tracking pipeline developments, mechanism classes, and market positioning to identify emerging threats and opportunities.

Knolscapes PD-L1 inhibitor timeline dashboard with competitor indication tracking

Knolscapes creates timeline visualizations of PD-L1 inhibitor approvals, tracking indications, manufacturers, and clinical applications. This consolidated view reveals approval patterns, indication expansions, and comparative positioning in small cell lung cancer.

Knolscapes biomarker-targeted therapy mapping for advanced esophageal cancer.

Knolscapes maps the biomarker landscape across immuno-oncology competitors, revealing which companies are pursuing similar targets. This intelligence helps you track emerging biomarker trends, identify potential collaborators, and differentiate your biomarker strategy

Knolscapes maps the biomarker landscape across immuno-oncology competitors, revealing which companies are pursuing similar targets. This intelligence helps you track emerging biomarker trends, identify potential collaborators, and differentiate your biomarker strategy

Competitive Intelligence

Choose your question from the below

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.
Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.
Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

Treatment guidelines comparison: Evidence-based due diligence across multiple therapeutic authorities

Knolens provides comprehensive treatment guideline analysis across key authorities, enabling rapid assessment of standard-of-care recommendations and biomarker-driven treatment pathways essential for licensing opportunity evaluation

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

Commercial potential of endometrial cancer therapies

Knolens evaluates scientific merit, clinical differentiation, and market opportunity for pipeline assets, enabling data-driven prioritization of BD opportunities

Knolscapes rare disease asset mapping with opportunity scoring

Knolscapes visualizes the rare disease landscape, highlighting preclinical and early clinical assets with breakthrough potential. This comprehensive mapping reveals promising technologies, scientific momentum, and competitive white space—accelerating asset identification and prioritization for BD teams

Knolscapes visualizes the rare disease landscape, highlighting preclinical and early clinical assets with breakthrough potential. This comprehensive mapping reveals promising technologies, scientific momentum, and competitive white space—accelerating asset identification and prioritization for BD teams

Business Development